# E5 Pharma LLC – FDA Inspection, Feb 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/e5-pharma-llc/66f9fdf6-c4f9-4fa2-9c64-de187434d20c
Source feed: FDA_Inspections

> FDA inspection 1197661 of E5 Pharma LLC, February 17, 2023. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR parts 310 and 314. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197661
- Company Name: E5 Pharma LLC
- Inspection Date: 2023-02-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Officers

- [Company Rep](https://www.keypedia.com/people/sheri-l-stephenson/dd4f3755-bb3b-4a14-a08f-8d59fbb0b6fa)

Company: https://www.keypedia.com/companies/e5-pharma-llc/cec53ef3-d0b7-4aff-9bf0-1b1c8325e302

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
